menu

Quintiles Library

Show Filters
Video
Learn about how we combine operational excellence, global reach, and medical expertise across all of our cardiac safety studies to deliver our value promise to you.
Video
One minute video on how Study Coordinators (SCs) can support in planning for recruitment in clinical trials.
Video
Quintiles and Investigators are helping to transform clinical development through relationships, communication, and processes.
Brochure
新しい成長の道筋を追及している業界にとっては、アジア太平洋は壮大な可能性を秘めています。一方、同地域は複雑な状況です。当局から承認を得るには、ローカルでの臨床試験を行い、独特な規制の枠組みに従っていかなければならないことが大半です。製品への理解を広めるため、さまざまな利用費の支払者や医療提供者と交渉して。絶えず変化する価格・支払金のスキームに対応しなければなりません。クインタイルズは、製品ライフサイクルの各段階を最適化する点で、実証済のアプローチを提供します。 コンテンツは日本語です。 For an industry looking for new paths to growth, the Asia Pacific region holds vast potential. Significant complexity also...
Read More
Press Release
RESEARCH TRIANGLE PARK, NC – March 7, 2016 – Quintiles, the world’s largest provider of product development and integrated healthcare services, has been recognized by the Ethisphere Institute, a global leader in defining and advancing the standards of ethical business practices, as a 2016 World’s Most Ethical Company®. This year marks the tenth anniversary of Ethisphere...
Read More
Press Release
RESEARCH TRIANGLE PARK, N.C. and CHICAGO, Ill. – March 4, 2016 – Quintiles and the American College of Surgeons (ACS) today announced a six-year strategic services agreement to improve data collection and quality reporting for all ACS clinical registries. Working together, ACS and Quintiles will build a comprehensive and integrated clinical registry platform that combines...
Read More
Press Release
RESEARCH TRIANGLE PARK, N.C. – February 29, 2016 – Quintiles COO Kevin Gordon will present at the Barclays Global Healthcare Conference on Tuesday, March 15, 2016 in Miami at the Loews Miami Beach Hotel. The Quintiles presentation will begin at 1:35 p.m. (EST). Investors may access a live audio webcast of the presentation on the Quintiles’ investor relations website at...
Read More
Case Study
Customer needs to respond to regulatory guidance issued on rigorous monitoring of cardiac safety by clinics six hours post-dose, with reporting requirements varying across geographies – because of the risk of transient bradycardias and heart block after the first dose, the FDA heightened the recommended level of cardiovascular monitoring of all patients after their first...
Read More
Video
Chris Cabell, senior vice president and head of the Therapeutic & Specialty Business Development team at Quintiles, discusses the challenges emerging biopharma companies face while bringing a drug to market and how choosing the right development partner can help alleviate the pressures of securing technology solutions, global experience, and talent, to focus on developing...
Press Release
RESEARCH TRIANGLE PARK, N.C. – February 22, 2016 – Quintiles, the world’s largest biopharmaceutical services company, has been named to Fortune magazine’s “World’s Most Admired Companies” list for 2016, the second year in a row for this distinction. Quintiles is ranked first overall in Fortune’s Healthcare: Pharmacy and Other Services industry category, up from number...
Read More
Press Release
RESEARCH TRIANGLE PARK, N.C. – February 17, 2015 – Quintiles CEO Tom Pike will present at the Raymond James & Associates 37th Annual Institutional Investors Conference on Monday, March 7, 2016 in Orlando, Florida at the JW Marriott Grande Lakes resort. The Quintiles presentation will begin at 2:50 p.m. (EST). Investors may access a live audio webcast of the...
Read More
Presentation
Payers, providers, patients and pharmaceutical companies are all interested in understanding the value of specific treatments protocols, whether these rely on medications, medical devices or other treatment modalities.  Additionally, there are different axes on which value can be measured, starting with traditionally defined clinical endpoints, but increasingly relying on...
Explore More
Fact Sheet
Now you can ease the administrative burden of clinical research – from study start up to close out. Quintiles Infosario Site Gateway gives you access to centralized data for your Quintiles-managed studies in one convenient online workspace. Since Quintiles uses this same system for site identification and selection, you can update your profile directly online to help...
Read More
Brochure
The cost of drug development is rising and healthcare budgets are constrained. By focusing on the value that the therapeutics provide, especially by improving outcomes for patients and strengthening relationships with physicians and payers, companies can optimize their route to market access with benefits for all stakeholders. Read our brochure to learn more
Read More
Infographic
What is a medical science liaison? Medical science liaisons (MSLs) are therapeutic specialists with advanced scientific training. They are experts in communicating complex scientific and medical information to a variety of stakeholders. The primary role of an MSL is to build and maintain strong relationships with KOLs in different therapeutic categories to help support...
Read More
Press Release
Research Triangle Park, NC, February 11, 2016 – Quintiles Transnational Holdings Inc. (“Quintiles” or the “Company”) (NYSE: Q) today reported its financial results for the quarter and year ended December 31, 2015. 9.4% constant currency service revenue growth compared to the fourth quarter of 2014 $0.90 diluted adjusted EPS representing 26.8% growth compared to...
Read More
Fact Sheet
  Evolving global pharmacovigilance regulations have recently put the spot-light on finding better and quicker ways to measure and assess medicinal product benefit-risk profiles through new requirements and guidelines.  Quintiles can help you better understand and comply with these changing regulations through our safety aggregate reporting and benefit-risk assessment...
Read More
Article
Success is often pre-determined by actions that take place very early in the development and commercialization cycle. The earlier companies start thinking through their launch strategy, the better. Read how 'Launch excellence' — the culmination of an iterative process that unifies clinical and commercial teams along with key stakeholder objectives — is imperative to...
Explore More
Infographic
Quintiles Allergy and Respiratory Center of Excellence is helping advance clinical trials through the use of global scientific, technological, and clinical resources. You can improve the speed, efficiency and quality for your global drug development programs across all respiratory indications.
Read More
Press Release
RESEARCH TRIANGLE PARK, N.C. – February 5, 2016 – Quintiles, the world’s largest biopharmaceutical services company, has been awarded the HR.com 2016 Leadership Excellence Award for Innovation in Deployment of Leadership Programs.    HR.com, the largest global social networking and resource site for HR professionals, is committed to providing a deeper understanding of...
Read More